Pharmacological properties
Pharmacodynamics. bronkholitin a tab — antibechic medicine of the central action. contains alkaloid glautsin, glaucinum flavum received from a plant (a machok yellow) which suppresses the center of cough. unlike codeine, glautsin does not influence a respiratory center and does not cause medicamentous dependence. he does not affect motility of intestines, shows weak spasmolytic activity, possesses sympatholytic action and can lower arterial blood pressure. possesses anti-inflammatory action.
Pharmacokinetics. At oral administration, medicine rezorbirutsya quickly in a GIT. Time of achievement of the C max in blood plasma — about 1.5 h after reception. It is metabolized in a liver and removed mainly with urine.
Indication
Symptomatic treatment of dry cough of various etiology at infectious and inflammatory diseases of the upper airways, including acute and chronic bronchitis, flu.
Use
Bronkholitin a tab is priment inside, it is recommended to take the medicament after a meal.
Adult. The single dose for adults makes 40 mg which is applied by 2–3 times a day. At more hard cases the single dose can be raised to 80 mg. The maximum daily dose should not exceed 200 mg.
Children aged from 4 years. The single dose makes 10 mg which is accepted by 2–3 times a day.
Maximum daily dose should not exceed 40 mg.
Patients with abnormal liver functions and kidneys. For patients with diseases of kidneys and a liver it is necessary to lower a dose of medicine or to increase an interval between receptions.
Duration of the Bronkholitin Tab medicament treatment should not exceed5 days. Use of medicine during longer period and in higher doses is possible only on appointment and under constant control of the doctor.
Contraindication
Hypersensitivity to acting or to any of medicine excipients; arterial hypotension; sharp myocardial infarction.
Side effects
Drug is characterized by good tolerance. seldom, at application of the high single dose exceeding 80 mg there can be dizziness, a headache, drowsiness, weakness and fast fatigue, nausea and vomiting, decrease hell. allergic reactions, including an itch, an enanthesis are possible.
If any of side effects becomes serious, administration of medicament needs to be stopped and notified on it the doctor.
needs to be notified byin case of the side effects which are not specified in this instruction immediately on it the doctor.
Special instructions
Bronkholitin a tab should not be applied at the productive cough which is followed by expectoration as there is a risk of an obturation of bronchial tubes as a result of a delay of a bronchial secret.
consultation of the doctor is necessary forin case of the labile ABP. Bronkholitin Tab it is necessary to apply with care because of risk of collapse as a result of sympatholytic action of a glautsin.
Drug contains in quality of excipient wheat starch which may contain gluten, but only in insignificant quantity therefore it is considered safe for persons with a Gee's disease.
to Patients with an allergy to wheat (other than a Gee's disease) should not apply this medicine.
Drug as excipient as a part of a cover contains sucrose. Patients with rare hereditary intolerance have a fructose, glyukozo-galaktozny malabsorption or deficiency of invertase-isomaltase it is not necessary to apply Bronkholitin Tab.
E 110 or E 124 Dye allergic reactions can cause.
Use during pregnancy and feeding by a breast. It is necessary to apply with care Bronkholitin Tab at the pregnant women and women nursing after ratio assessment advantage/risk.
Children. Not to use medicament for treatment of children under 4 years.
Ability to influence speed of response at control of vehicles or other mechanisms. If during medicament treatment the dizziness, a headache, drowsiness, weakness and fast fatigue develop, it is necessary to refrain from control of vehicles and work with mechanisms.
do not have
Interaction
data on the known adverse medicinal interactions with medicine bronkholitin a tab. it can be applied in a combination with antibiotics, chemotherapeutic means and other medicines.Bronkholitin Tab should not be applied along with the medicines oppressing cough as central (codeine, Codterpinum), and the peripheral mechanism of action (eksangit, Prenoxdiazinum). The combination with the medicines causing decrease in bronchial secretion is not justified (for example atropine derivatives).
Bronkholitin Tab can be applied along with bronchodilators, cardiovascular medicines.
Active agent is effectively combined bywith ephedrine, citric acid, basil oil in the combined medicaments in the form of syrups for decrease in intensity of cough.
Overdose
Symptoms: dizziness, headache, drowsiness, weakness and fast fatigue, nausea, vomiting, decrease hell.
Treatment: take the standard measures for fast removal of medicine from an organism (gastric lavage, use of activated carbon, infusion of water-salt solutions) and also carry out symptomatic treatment.
Storage conditions
In original packing at a temperature not above 25 °C.
Characteristics | |
Active ingredients | Glautsin |
Amount of active ingredient | 40 mg |
Applicant | Sopharma |
Code of automatic telephone exchange | R05DB Other antibechics |
Interaction with food | Later |
Light sensitivity | Not sensitive |
Market status | Traditional |
Origin | Vegetable |
Prescription status | Without prescription |
Primary packing | blister |
Producer | AT SOFARMA |
Quantity in packing | 20 tablets |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Import |
Storage temperature | from 5 °C to 25 °C |
Trade name | Bronkholitin |
Bronkholitin Tab of the tab. of p/o of 40 mg No. 20
- Product Code: 180238
- In Stock
- Ready to ship
-
$25.09